PAPER Kittelberger KA, Piazza F, Tesco G, Reijmers LG
SEARCH RESULTS
329960 RESULTS
PAPER Ohta H, Arai S, Akita K, Ohta T, Fukuda S
Effects of NK-4 in a transgenic mouse model of Alzheimer's disease.
PLoS One. 2012;7(1):e30007. PubMed: 22238689PAPER Jumpertz T, Rennhack A, Ness J, Baches S, Pietrzik CU, Bulic B, Weggen S
Presenilin is the molecular target of acidic γ-secretase modulators in living cells.
PLoS One. 2012;7(1):e30484. PubMed: 22238696PAPER Tamaoka A
[108th Scientific Meeting of the Japanese Society of Internal Medicine: symposium: 1. Progress in dementia research--dementia disorders and protein; (2) amyloid P3 protein].
Nihon Naika Gakkai Zasshi. 2011 Sep 10;100(9):2469-75. PubMed: 22117336PAPER Muñoz-Torrero D, Pera M, Relat J, Ratia M, Galdeano C, Viayna E, Sola I, Formosa X, Camps P, Badia A, Clos MV
Expanding the Multipotent Profile of Huprine-Tacrine Heterodimers as Disease-Modifying Anti-Alzheimer Agents.
Neurodegener Dis. 2012 Jan 6; PubMed: 22236498PAPER Schulz R, Cook TB, Beach SR, Lingler JH, Martire LM, Monin JK, Czaja SJ
Magnitude and Causes of Bias Among Family Caregivers Rating Alzheimer Disease Patients.
Am J Geriatr Psychiatry. 2012 Jan 10; PubMed: 22237250PAPER Johnson D, Allman E, Nehrke K
Regulation of acid-base transporters by reactive oxygen species following mitochondrial fragmentation.
Am J Physiol Cell Physiol. 2012 Apr;302(7):C1045-54. PubMed: 22237403PAPER Martinez-Martin P, Falup Pecurariu C, Odin P, van Hilten JJ, Antonini A, Rojo-Abuin JM, Borges V, Trenkwalder C, Aarsland D, Brooks DJ, Ray Chaudhuri K
Gender-related differences in the burden of non-motor symptoms in Parkinson's disease.
J Neurol. 2012 Jan 12; PubMed: 22237822PAPER Murgas P, Godoy B, von Bernhardi R
Aβ Potentiates Inflammatory Activation of Glial Cells Induced by Scavenger Receptor Ligands and Inflammatory Mediators in Culture.
Neurotox Res. 2012 Jan 12; PubMed: 22237943PAPER Matenia D, Hempp C, Timm T, Eikhof A, Mandelkow EM
Microtubule Affinity-regulating Kinase 2 (MARK2) Turns on Phosphatase and Tensin Homolog (PTEN)-induced Kinase 1 (PINK1) at Thr-313, a Mutation Site in Parkinson Disease: EFFECTS ON MITOCHONDRIAL TRANSPORT.
J Biol Chem. 2012 Mar 9;287(11):8174-86. PubMed: 22238344PAPER Wagner M, Wolf S, Reischies FM, Daerr M, Wolfsgruber S, Jessen F, Popp J, Maier W, Hüll M, Frölich L, Hampel H, Perneczky R, Peters O, Jahn H, Luckhaus C, Gertz HJ, Schröder J, Pantel J, Lewczuk P, Kornhuber J, Wiltfang J
Biomarker validation of a cued recall memory deficit in prodromal Alzheimer disease.
Neurology. 2012 Feb 7;78(6):379-86. PubMed: 22238414PAPER Swerdlow RH, Jicha GA
Alzheimer disease: can the exam predict the pathology?
Neurology. 2012 Feb 7;78(6):374-5. PubMed: 22238417PAPER Boström P, Wu J, Jedrychowski MP, Korde A, Ye L, Lo JC, Rasbach KA, Boström EA, Choi JH, Long JZ, Kajimura S, Zingaretti MC, Vind BF, Tu H, Cinti S, Højlund K, Gygi SP, Spiegelman BM
A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis.
Nature. 2012 Jan 11; PubMed: 22237023PAPER Wenz T, Rossi SG, Rotundo RL, Spiegelman BM, Moraes CT
Increased muscle PGC-1alpha expression protects from sarcopenia and metabolic disease during aging.
Proc Natl Acad Sci U S A. 2009 Dec 1;106(48):20405-10. PubMed: 19918075PAPER Hanney M, Prasher V, Williams N, Jones EL, Aarsland D, Corbett A, Lawrence D, Yu LM, Tyrer S, Francis PT, Johnson T, Bullock R, Ballard C, MEADOWS trial researchers
Memantine for dementia in adults older than 40 years with Down's syndrome (MEADOWS): a randomised, double-blind, placebo-controlled trial.
Lancet. 2012 Feb 11;379(9815):528-36. Epub 2012 Jan 10 PubMed: 22236802Current Filters
No filters selected